Novo Nordisk: Fourth Quarter Earnings Overview

Novo Nordisk Announces Strong Fourth-Quarter Results

Novo Nordisk A/S, headquartered in Bagsvaerd, Denmark, revealed a net profit of $4.19 billion for the fourth quarter.

The company reported earnings of $0.94 per share, with adjusted earnings—excluding one-time expenses—reaching $1 per share.

These figures exceeded analyst expectations, as a consensus of five analysts polled by Zacks Investment Research had forecasted earnings of $0.90 per share.

Quarterly revenue reached $12.34 billion, surpassing the $12.08 billion anticipated by three Zacks analysts.

For the full year, Novo Nordisk achieved a net income of $15.51 billion, or $3.49 per share, with total revenue amounting to $46.8 billion.